ANGO
AngioDynamics, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
+18/100
Last price
14.42
▼ 1.12 (7.21%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
15.70
Prev close
15.54
Day high
15.63
Day low
14.23
Volume
847.54K
Market cap
$606.43M
P/E (TTM)
—
52W range
9.39 – 16.29
Day trading desk
Gap from prior close
+1.06%
Prior close 15.54
VWAP
14.57
-1.00% from price
Relative volume
1.52×
Unusually busy
Session range
11.94%
14.23 – 15.93
Position in range
11%
Near session low
ATR (14D)
0.58
4.00% of price
Prior day high
15.63
PDH
Prior day low
14.92
PDL
Bid / ask spread
—
Quote not published
Session volume
763.44K
Avg 502.90K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-7.56%
-9.5%
1M
-5.13%
-6.3%
3M
+12.57%
+8.0%
6M
+48.66%
+30.5%
YTD
+12.31%
-1.9%
1Y
+23.88%
+7.5%
3Y
+97.26%
+15.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ANGO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+277.15K
Net buying
Buy transactions
17
300.52K shares
Sell transactions
1
23.37K shares
Net transactions
+18
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
5.41M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 30, 26 | NIGHAN WARREN G JR Officer |
SELL | 23.37K | $344.01K | Direct |
| Jul 22, 26 | CLEMMER JAMES C Chief Executive Officer |
— | 52.36K | — | Direct |
| Jul 22, 26 | NIGHAN WARREN G JR Officer |
— | 5.69K | — | Direct |
| Jul 22, 26 | TROWBRIDGE STEPHEN A Chief Financial Officer |
— | 16.30K | — | Direct |
| Jul 22, 26 | CAMPBELL CHAD THOMAS Officer |
— | 6.47K | — | Direct |
| Jul 22, 26 | PICCININI LAURA Officer |
— | 8.05K | — | Direct |
| Jul 15, 26 | NIGHAN WARREN G JR Officer |
STOCK | 17.97K | $0 | Direct |
| Jul 15, 26 | TARNOFF MICHAEL E Director |
STOCK | 11.89K | $0 | Direct |
| Jul 15, 26 | TROWBRIDGE STEPHEN A Chief Financial Officer |
STOCK | 53.26K | $0 | Direct |
| Jul 15, 26 | CAMPBELL CHAD THOMAS Officer |
STOCK | 16.08K | $0 | Direct |
| Jul 15, 26 | LICITRA KAREN A. Director |
STOCK | 11.89K | $0 | Direct |
| Jul 15, 26 | BURGESS LORINDA Director |
STOCK | 11.89K | $0 | Direct |
| Jul 15, 26 | PICCININI LAURA Officer |
STOCK | 19.86K | $0 | Direct |
| Jul 15, 26 | LAWRENCE WEISS T Officer |
STOCK | 21.29K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
AUEN EILEEN O SHEA |
Director | 116.61K | Stock Award(Grant) |
CAMPBELL CHAD THOMAS |
Officer | 108.68K | Conversion of Exercise of derivative security |
CLEMMER JAMES C |
Chief Executive Officer | 862.45K | Conversion of Exercise of derivative security |
DONNELLY HOWARD W |
Director | 178.94K | Stock Award(Grant) |
JOHNSON WESLEY E JR |
Director | 155.43K | Stock Award(Grant) |
LAWRENCE WEISS T |
Officer | 112.62K | Stock Award(Grant) |
LICITRA KAREN A. |
Director | 102.32K | Stock Award(Grant) |
REED JAN STERN J.D. |
Director | 116.92K | Stock Award(Grant) |
TARNOFF MICHAEL E |
Director | 95.27K | Stock Award(Grant) |
TROWBRIDGE STEPHEN A |
Chief Financial Officer | 305.80K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$606.43M
Enterprise value$553.11M
Revenue (TTM)$320.17M
Gross profit$174.89M
EBITDA$188.00K
Net income$-36.74M
EPS (TTM)$-0.88
Free cash flow$21.77M
Total cash$53.86M
Total debt$10.96M
Book value / share$4.10
Shares outstanding42.05M
Float31.79M
Short % of float3.46%
Dividend yield0.00%
Beta (5Y)0.30
Valuation & profitability ratios
Trailing P/E—
Forward P/E-320.44
PEG ratio1.41
Price / sales—
Price / book3.52
EV / revenue1.73
EV / EBITDA2,942.05
Gross margin54.62%
Operating margin-6.52%
Profit margin-11.48%
Return on equity-20.77%
Return on assets-5.13%
Debt / equity6.41
Current ratio2.19
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $320.17M | $292.50M | $303.91M | $338.75M | +9.5% |
| Operating revenue | $320.17M | $292.50M | $303.91M | $338.75M | +9.5% |
| Cost of revenue | $145.28M | $134.79M | $149.22M | $164.51M | +7.8% |
| Gross profit | $174.89M | $157.71M | $154.70M | $174.25M | +10.9% |
| Research & development | $29.45M | $26.22M | $31.51M | $29.88M | +12.3% |
| Selling, general & admin | $157.09M | $145.23M | $143.98M | $144.25M | +8.2% |
| Total operating expense | $197.22M | $181.77M | $188.54M | $192.93M | +8.5% |
| Operating income | -$22.33M | -$24.06M | -$33.84M | -$18.68M | +7.2% |
| Net interest income | -$299.00K | $978.00K | $1.61M | -$2.70M | -130.6% |
| Pre-tax income | -$36.30M | -$34.03M | -$191.64M | -$54.44M | -6.7% |
| Tax provision | $442.00K | -$39.00K | -$7.29M | -$2.00M | +1,233.3% |
| Net income | -$36.74M | -$33.99M | -$184.35M | -$52.44M | -8.1% |
| Net income to common | -$36.74M | -$33.99M | -$184.35M | -$52.44M | -8.1% |
| Basic EPS | -0.88 | -0.83 | -4.59 | -1.33 | -6.0% |
| Diluted EPS | -0.88 | -0.83 | -4.59 | -1.33 | -6.0% |
| EBIT | -$22.33M | -$24.06M | -$33.84M | -$18.68M | +7.2% |
| EBITDA | $626.00K | $1.74M | -$6.13M | $12.19M | -64.0% |
| Basic shares | 41.53M | 40.85M | 40.18M | 39.48M | +1.6% |
| Diluted shares | 41.53M | 40.85M | 40.18M | 39.48M | +1.6% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $53.86M | $55.89M | $76.06M | $44.62M | — | -3.6% |
| Cash & short-term investments | $53.86M | $55.89M | $76.06M | $44.62M | — | -3.6% |
| Accounts receivable | $48.33M | $42.89M | $43.61M | $52.83M | — | +12.7% |
| Inventory | $52.44M | $62.01M | $60.62M | $55.33M | — | -15.4% |
| Total current assets | $163.39M | $168.32M | $193.25M | $163.54M | — | -2.9% |
| Property, plant & equipment | $27.10M | $32.30M | $35.67M | $44.38M | — | -16.1% |
| Goodwill & intangibles | $67.21M | $69.12M | $77.38M | $270.38M | — | -2.8% |
| Total assets | $267.16M | $280.14M | $317.67M | $532.64M | — | -4.6% |
| Total current liabilities | $74.72M | $76.20M | $91.16M | $83.83M | — | -1.9% |
| Current debt | — | — | $4.73M | $14.76M | $8.78M | — |
| Long-term debt | — | — | — | $49.82M | $25.00M | — |
| Total debt | — | — | $4.73M | $64.58M | $33.78M | — |
| Total liabilities | $96.34M | $97.17M | $112.08M | $154.34M | — | -0.9% |
| Retained earnings | -$465.94M | -$429.20M | -$395.20M | -$210.85M | — | -8.6% |
| Shareholder equity | $170.82M | $182.97M | $205.59M | $378.30M | — | -6.6% |
| Working capital | $88.68M | $92.13M | $102.10M | $79.72M | — | -3.7% |
| Net tangible assets | $103.62M | $113.85M | $128.20M | $107.91M | — | -9.0% |
| Shares issued | 42.31M | 41.61M | 40.80M | 39.98M | — | +1.7% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | -$36.74M | -$33.99M | -$184.35M | -$52.44M | -8.1% |
| Depreciation & amortisation | $22.95M | $25.80M | $27.71M | $30.87M | -11.0% |
| Stock-based compensation | $13.96M | $9.77M | $10.53M | $11.16M | +42.9% |
| Change in working capital | -$2.66M | -$14.11M | $14.42M | -$7.03M | +81.2% |
| Operating cash flow | $3.09M | -$10.13M | -$28.16M | $78.00K | +130.5% |
| Capital expenditure | -$2.58M | -$4.46M | -$5.77M | -$4.35M | +42.2% |
| Investing cash flow | -$5.95M | -$10.18M | $123.72M | -$9.75M | +41.6% |
| Share buybacks | $0 | -$1.67M | $0 | $0 | +100.0% |
| Financing cash flow | $564.00K | -$255.00K | -$64.25M | $25.42M | +321.2% |
| Free cash flow | $508.00K | -$14.59M | -$33.93M | -$4.27M | +103.5% |
| End cash position | $53.86M | $55.89M | $76.06M | $44.62M | -3.6% |
| Line item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $86.61M | $78.42M | $79.43M | $75.71M | $80.16M | — | +10.4% |
| Operating revenue | $86.61M | $78.42M | $79.43M | $75.71M | $80.16M | — | +10.4% |
| Cost of revenue | $39.83M | $36.94M | $34.65M | $33.85M | $37.94M | — | +7.8% |
| Gross profit | $46.77M | $41.48M | $44.78M | $41.86M | $42.22M | — | +12.8% |
| Research & development | $8.18M | $7.08M | $7.77M | $6.42M | $6.59M | — | +15.4% |
| Selling, general & admin | $41.39M | $38.16M | $36.86M | $40.69M | $36.67M | — | +8.5% |
| Total operating expense | $52.28M | $47.91M | $47.27M | $49.76M | $45.85M | — | +9.1% |
| Operating income | -$5.51M | -$6.43M | -$2.49M | -$7.90M | -$3.63M | — | +14.3% |
| Net interest income | -$105.00K | -$88.00K | -$102.00K | -$4.00K | $3.00K | — | -19.3% |
| Pre-tax income | -$11.04M | -$8.07M | -$6.36M | -$10.84M | -$6.11M | — | -36.7% |
| Tax provision | $370.00K | $12.00K | -$5.00K | $65.00K | -$60.00K | — | +2,983.3% |
| Net income | -$11.40M | -$8.08M | -$6.35M | -$10.90M | -$6.05M | — | -41.1% |
| Net income to common | -$11.40M | -$8.08M | -$6.35M | -$10.90M | -$6.05M | — | -41.1% |
| Basic EPS | -0.27 | -0.19 | -0.15 | -0.26 | -0.15 | — | -42.1% |
| Diluted EPS | -0.27 | -0.19 | -0.15 | -0.26 | — | -0.11 | -42.1% |
| EBIT | -$5.51M | -$6.43M | -$2.49M | -$7.90M | -$3.63M | — | +14.3% |
| EBITDA | $85.00K | -$838.00K | $3.26M | -$1.88M | $2.20M | — | +110.1% |
| Basic shares | 41.70M | 41.60M | 41.54M | 41.17M | 40.98M | — | +0.2% |
| Diluted shares | 41.70M | 41.60M | 41.54M | 41.17M | 40.98M | — | +0.2% |
| Line item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $53.86M | $37.81M | $41.64M | $38.76M | $55.89M | — | +42.5% |
| Cash & short-term investments | $53.86M | $37.81M | $41.64M | $38.76M | $55.89M | — | +42.5% |
| Accounts receivable | $48.33M | $45.55M | $44.43M | $42.64M | $42.89M | — | +6.1% |
| Inventory | $52.44M | $58.58M | $65.57M | $62.26M | $62.01M | — | -10.5% |
| Total current assets | $163.39M | $155.55M | $161.35M | $156.66M | $168.32M | — | +5.0% |
| Property, plant & equipment | $27.10M | $29.14M | $30.53M | $31.07M | $32.30M | — | -7.0% |
| Goodwill & intangibles | $67.21M | $65.49M | $66.73M | $68.38M | $69.12M | — | +2.6% |
| Total assets | $267.16M | $260.68M | $269.68M | $265.64M | $280.14M | — | +2.5% |
| Total current liabilities | $74.72M | $66.07M | $71.96M | $68.28M | $76.20M | — | +13.1% |
| Current debt | — | — | — | — | — | $5.00M | — |
| Total debt | — | — | — | — | — | $5.00M | — |
| Total liabilities | $96.34M | $87.32M | $93.35M | $86.79M | $97.17M | — | +10.3% |
| Retained earnings | -$465.94M | -$454.53M | -$446.45M | -$440.10M | -$429.20M | — | -2.5% |
| Shareholder equity | $170.82M | $173.36M | $176.33M | $178.85M | $182.97M | — | -1.5% |
| Working capital | $88.68M | $89.49M | $89.39M | $88.37M | $92.13M | — | -0.9% |
| Net tangible assets | $103.62M | $107.87M | $109.60M | $110.47M | $113.85M | — | -3.9% |
| Shares issued | 42.31M | 42.30M | 42.19M | 42.06M | 41.61M | — | +0.0% |
| Line item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$11.40M | -$8.08M | -$6.35M | -$10.90M | -$6.05M | -41.1% |
| Depreciation & amortisation | $5.60M | $5.59M | $5.75M | $6.02M | $5.83M | +0.1% |
| Stock-based compensation | $3.92M | $2.68M | $2.89M | $4.47M | $1.64M | +45.9% |
| Change in working capital | $16.51M | -$4.45M | $1.56M | -$16.27M | $16.73M | +470.9% |
| Operating cash flow | $17.45M | -$3.11M | $4.66M | -$15.91M | $18.81M | +661.2% |
| Capital expenditure | -$413.00K | -$1.01M | -$422.00K | -$731.00K | -$777.00K | +59.3% |
| Investing cash flow | -$1.27M | -$1.51M | -$1.62M | -$1.55M | -$2.62M | +15.7% |
| Share buybacks | $0 | $0 | $0 | $0 | $0 | — |
| Financing cash flow | -$108.00K | $621.00K | -$92.00K | $143.00K | -$5.77M | -117.4% |
| Free cash flow | $17.04M | -$4.13M | $4.24M | -$16.64M | $18.03M | +513.1% |
| End cash position | $53.86M | $37.81M | $41.64M | $38.76M | $55.89M | +42.5% |
Options analytics
Put / call volume
2.01
Put-heavy session
Put / call open interest
0.77
Positioning, not flow
Max pain
12.50
-13.3% from spot
ATM implied vol
136.1%
Nearest strike to spot
Skew (10% OTM)
+32.6%
Puts bid over calls
Call volume
140
Contracts, this expiry
Put volume
282
Contracts, this expiry
Heaviest call OI
17.50
273 contracts
Heaviest put OI
7.50
296 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| May 2026 | -0.09 | -0.07 | +22.2% |
| Feb 2026 | -0.11 | 0.02 | +118.2% |
| Nov 2025 | -0.10 | 0.00 | +100.0% |
| Aug 2025 | -0.12 | -0.10 | +18.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.11 | 3 | $80.50M | +6.3% |
| Next quarter | -0.08 | 3 | $84.08M | +5.8% |
| Current year | -0.27 | 3 | $337.32M | +5.4% |
| Next year | -0.05 | 2 | $355.17M | +5.3% |
Analyst targets & ownership
Mean target$20.00
High target$24.00
Low target$17.00
Implied upside38.70%
Analyst count4
ConsensusNONE
Strong buy / Buy0 / 4
Hold0
Sell / Strong sell0 / 0
Held by insiders13.09%
Held by institutions92.48%
Institutions holding213
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
15.30
-5.75% from price
SMA 20
15.37
-6.17% from price
SMA 50
15.45
-6.67% from price
SMA 100
13.97
+3.20% from price
SMA 200
12.49
+15.42% from price
EMA 12
15.25
-5.44% from price
EMA 26
15.33
-5.93% from price
EMA 50
15.06
-4.22% from price
RSI (14)
35.4
Neutral
MACD (12,26,9)
-0.08
Hist -0.09
ATR (14)
0.58
4.00% of price
Realised vol 30D
28.7%
Annualised
Bollinger upper
15.90
20, 2σ
Bollinger lower
14.83
20, 2σ
50 / 200 cross
Golden
15.45 vs 12.49
Trend bias
Above 200
+15.42%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.93
Less volatile than market
Correlation to SPY
0.28
Largely independent
Realised vol 30D
28.7%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-28.9%
Peak to trough
Max drawdown 5Y
-83.0%
Peak to trough
ATR 14
0.58
4.00% of price
Beta (reported)
0.30
5Y monthly, from filing
Short interest
Shares short
1.34M
Prior 1.35M
Change vs prior
-0.7%
Shorts covering
% of float
3.46%
Normal
% of shares out
3.25%
Against total outstanding
Days to cover
4.2
Liquid
Float
31.79M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 15, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jul 15, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Apr 6, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Apr 6, 26 | Freedom Broker | INITIATED | — | Buy |
| Oct 3, 25 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 16, 25 | Lake Street | INITIATED | — | Buy |
| Jul 16, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jul 16, 25 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Apr 7, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jan 10, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jan 9, 25 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Dec 10, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-K/A · 2026-09-29
Periodic Financial Reports
10-K · 2026-07-14
Corporate Changes & Voting Matters
8-K · 2026-04-23
Corporate Changes & Voting Matters
8-K · 2026-04-02
Corporate Changes & Voting Matters
8-K · 2026-02-03
Corporate Changes & Voting Matters
8-K · 2026-01-14
Periodic Financial Reports
10-Q · 2026-01-06
Corporate Changes & Voting Matters
8-K · 2025-11-12
Headlines
Delta Stock Struggles As Revenue Growth Accelerates; Will Its Results Pass Muster?
Investor's Business Daily · 5d ago
AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism Evidence
Business Wire · 5d ago
AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026
Business Wire · 8d ago
AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027
MarketBeat · 56d ago
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
Zacks · 61d ago
ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus
Zacks · 61d ago
ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?
Zacks · 61d ago
AngioDynamics to Participate in Upcoming Investor Conferences
Business Wire · 71d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.